Aimmune Therapeutics (AIMT) PT Raised to $44 at JMP Securities
Tweet
Share
E-mailGet Alerts AIMT Hot Sheet
Price: $34.49 --0%
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 4 | New: 19
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 4 | New: 19
Join SI Premium – FREE
JMP Securities analyst Liisa Bayko raised the price target on Aimmune Therapeutics (NASDAQ: AIMT) to $44.00 (from $40.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Barclays Upgrades Visteon (VC) to Overweight
- Food & Life Companies (3563:JP) PT Raised to JPY12,500 at Macquarie
- Fast Retailing Co Ltd. (9983:JP) (FRCOY) PT Raised to JPY90,000 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
